Jmp version 14 for windows

Manufactured by SAS Institute

Sourced in United States

JMP version 14 for Windows is a statistical discovery software that enables users to explore data, uncover patterns, and gain insights. It provides a wide range of analytical capabilities, including data visualization, modeling, and reporting.

Automatically generated - may contain errors

Lab products found in correlation

Spelling variants of this product

JMP 14 (902 citations) JMP version 14 (447 citations) JMP 14 for Windows (3 citations) JMP software version 14.2 for Windows (2 citations) JMP software program for Windows version 14 (2 citations)

5 protocols using jmp version 14 for windows

Iron Status and Cardiovascular Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols

Continuous variables were expressed as mean ± standard deviation and compared using Student’s t-test. Categorical variables were summarized with frequency percentages and analyzed using a chi-square test. Cumulative event-free rates during follow-up were derived using the Kaplan–Meier method. Univariate and multivariable analyses of events were performed using Cox proportional hazards models. We implemented five models for the adjustment of covariates: model 1, unadjusted; model 2, adjusted for age and sex; model 3, adjusted for all factors in model 2 plus hemoglobin, estimated glomerular filtration rate (eGFR), brain natriuretic peptide (BNP), and LVEF; model 4, adjusted for all factors in model 3 plus ferritin level and transferrin saturation (TSAT); and model 5, adjusted for factors related to anemia and iron balance including hemoglobin, mean corpuscular volume (MCV), ferritin, transferrin level, and TSAT.
Results were reported as hazard ratios (HR), 95% confidence intervals (CI), and P-values. The HR for outcomes in the Low iron group was compared with that for outcomes in the High iron group, which served as the reference group. Variables with P-values < 0.05 were retained in the model. JMP version 14 for Windows (SAS Institute, Cary, NC, USA) was used for all statistical analyses.

Ueda T., Kawakami R., Nogi K., Nogi M., Ishihara S., Nakada Y., Nakano T., Hashimoto Y., Nakagawa H., Nishida T., Onoue K., Soeda T., Okayama S., Watanabe M, & Saito Y. (2021). Serum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure. Scientific Reports, 11, 2395.

+ Open protocol

+ Expand

Epidemiological Analysis of Disease Onset

Check if the same lab product or an alternative is used in the 5 most similar protocols

Results are presented as median and interquartile range (IQR). The chi-squared test or Fisher's exact test was used to compare variables between each group. Wilcoxon's ranksum test was used to compare median differences in age of onset between each experimental group. Statistical analysis was performed using standard statistical software (JMP version 14 for Windows; SAS Institute, Cary, NC, USA). In all tests, p < 0.05 was considered statistically significant.

Ichikawa Y., Sakakibara N., Nagano C., Inoki Y., Tanaka Y., Ueda C., Kitakado H., Kondo A., Ishimori S., Horinouchi T., Iijima K, & Nozu K. (2024). In steroid-resistant nephrotic syndrome that meets the strict definition, monogenic variants are less common than expected. Pediatric nephrology (Berlin, Germany).

+ Open protocol

+ Expand

Prognostic Factors in Hepatocellular Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols

Categorical variables were compared using the Fisher exact test between the groups. Continuous variables were expressed as medians with ranges, and compared using the Mann-Whitney U test between the groups. The overall survival rates and relapse-free survival rates were calculated using the Kaplan-Meier method and compared between the groups using the log-rank test. Potential prognostic factors were identified by univariate analysis using the logrank test. Independent prognostic factors were evaluated using a Cox proportional-hazards regression model. Differences in the clinicopathological backgrounds between the DR and non-DR cases were propensity score matched (PSM) at a 1:1 ratio. Nine variables (age, HCV antibody, Child-Pugh classification, AFP, tumor node metastasis (TNM) stage, tumor size, differentiation, portal vein invasion, and hepatic vein invasion) were entered into the propensity score, and the caliper was set to 0.20. In this study, p < 0.05 was considered significant. All statistical analyses were performed using JMP version 14 for Windows (SAS Institute, Cary, NC).

Orimo T., Kamiyama T., Wakayama K., Shimada S., Nagatsu A., Asahi Y., Sakamoto Y., Kamachi H, & Taketomi A. (2020). Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis. Annals of surgical oncology, 27(11).

+ Open protocol

+ Expand

Factors Influencing Palliative Care in Japan

Check if the same lab product or an alternative is used in the 5 most similar protocols

All statistical analyses was performed with JMP version 14 for Windows (SAS, Cary, NC, USA). First, we performed descriptive analyses to summarize baseline characteristics. Second, we performed Wilcoxon rank-sum tests for continuous variables, Cochran-Armitage trend tests for ordinal variables and Fisher's exact tests for categorical variables to identify the factors related to SPC and aggressive care. Third, we used those variables with p values of <0.2 in the univariate analysis for nal model tting with multivariate logistic regression to identify the factors related to SPC and aggressive care. We regarded p values of <0.05 as statistically signi cant in the nal model.
This study was conducted in accordance with the ethical standards of the Declaration of Helsinki and the ethical guidelines for medical and health research involving human subjects presented by the Ministry of Health, Labour and Welfare in Japan. The primary responsible physicians obtained written informed consent from all patients. The independent ethics committee of the Tohoku University School of Medicine approved this study (approval no. 2014-1-085).

Hiratsuka Y., Oishi T., Miyashita M., Morita T., Mack J.W., Sato Y., Takahashi M., Komine K., Saijo K., Ishioka C, & Inoue A. (2021). Factors related to specialized palliative care use and aggressive care at end of life in Japanese patients with advanced solid cancers: a cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(12).

+ Open protocol

+ Expand

End-of-Life Symptom Profiles in East Asian Cancer Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols

All analyses were performed using JMP version 14 for Windows (SAS, Cary, NC, USA).
First, we classi ed study participants into 3 groups according to the type of primary cancer prevailing in East Asia: digestive tract, lung and others. Digestive tract cancer includes gastroesophageal, colorectal, hepatobiliary, and pancreatic cancer. Lung cancer includes small-cell and non-small cell types. Other cancers include breast, gynecological, urological, head and neck, bone and soft tissue, skin, brain cancer and hematological malignancies.
Second, we performed descriptive analyses to summarize baseline characteristics of study participants according to the type of primary cancer.
Third, descriptive analyses were summarized as the prevalence of physical and psychological symptoms and signs according to the type of primary cancer in patients at admission, 1 week after admission and in the last 3 days of life. We de ned 'present symptoms' as having more than one point of score of the response scale.
Fourth, we compared the severity of physical and psychological symptoms and signs in the last 3 days of life according to the type of primary cancer using one-way analysis of variance (ANOVA). Post hoc analysis was conducted using Tukey-Kramer test for multiple comparisons of each symptom according to the type of primary cancer.

Hiratsuka Y., Suh S.Y., Won S.H., Kim S.H., Yoon S.J., Koh S.J., Kwon J.H., Park J., Ahn H.Y., Cheng S.Y., Chen P.J., Yamaguchi T., Morita T., Tsuneto S., Mori M, & Inoue A. (2022). Prevalence and severity of symptoms and signs in patients with advanced cancer in the last days of life: the East Asian collaborative cross-cultural study to elucidate the dying process (EASED). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 30(6).

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!